Administrative Core

行政核心

• 批准号: 10261953
• 负责人: Monica Kraft
• 金额: $ 14.68万
• 依托单位: UNIVERSITY OF ARIZONA
• 依托单位国家: 美国
• 财政年份: 2016
• 资助国家: 美国
• 起止时间: 2016-06-01 至 2026-05-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10261953
• 关键词: 2019-nCoV; Adherence; Advisory Committees; Allergic Disease; Anions; Arizona; Asthma; Attenuated; Biological; Biological Response Modifiers; Collaborations; Collection; Communication; Communities; Data; Data Analyses; Ensure; Ethics; Fostering; Funding Opportunities; Future; Grant; Guidelines; Health; Human Resources; Immune; Immune response; Immunologic Factors; Immunomodulators; Infection; Inflammation; Inflammatory Response; Influenza A virus; Information Dissemination; Infrastructure; Institution; Lipids; Mediator of activation protein; Medical center; Molecular; Monitor; Natural Immunity; Participant; Performance; Phosphatidylglycerols; Phosphatidylinositols; Program Reviews; Publications; Pulmonary Surfactant-Associated Protein A; Recording of previous events; Regulation; Research; Research Activity; Research Personnel; Resources; Role; Sampling; Schedule; Shipping; TOLLIP gene; Time; Translating; Travel; United States National Institutes of Health; Universities; Vertebrates; Viral; Virus Diseases; Vision; Work; asthma exacerbation; base; clinical practice; conflict resolution; cost; data management; follower of religion Jewish; human subject; innate immune mechanisms; meetings; member; novel therapeutics; operation; programs; success; surfactant; symposium; synergism

This U19 Asthma and Allergic Diseases Cooperative Research Center (AACDRC) Program brings together a team of investigators in three interactive projects and two cores to focus on the pathobiology of specific innate immune mechanisms in viral infection and asthma. In the renewal of our AADCRC program, we will continue to focus on the critical and often understudied innate immune factors surfactant protein-A (SP-A), the anion lipids of surfactant, (palmitoyl-oleoyl-phosphatidylglycerol (POPG) and phosphatidylinositol (PI)) and Toll interacting protein (Tollip), an innate immune mediator known to cross talk with SP-A and the anionic lipids. Each of these mediators works synergistically to modulate inflammatory and immunologic responses in asthma and infection given their complementary functions. Our exciting preliminary data underpin our program’s overall hypothesis that POPG/PI, Tollip and SP-A function as unique immune modulators that attenuate the impact of specific viral infections (RV-C, Influenza A and SARS-CoV-2) in type-2 asthma. The investigators in this program have a long history of collaboration at the. University of Arizona and National Jewish Health; Cedar Sinai Medical Center is now included in this renewal. The Administrative Core (Core A) of this Program will perform an important role to maintain productive and vibrant collaboration, ensure and track adherence to NIH and other relevant regulations and guidelines, and manage activities that will continue to strengthen the research community surrounding this Program. The Administrative Core has the following Specific Aims: (1) Manage the day-to-day administrative details and programmatic needs of the AADCRC program by providing fiscal management, administering subcontracts, assuring that regulatory requirements in are met, and monitoring of progress with program objectives; (2) Create an infrastructure to facilitate communication between the projects, cores and. investigators, and NIH Program Directors and to provide conflict resolution should it be necessary; (3) Assist with dissemination of research findings in a timely fashion to the scientific community, both locally and nationally, and provide information to the public, including study participants; 4) Implement the Infrastructure and Opportunity Fund for the AADCRC. Our proposal builds upon our active and productive collaborations of over 20 years and will significantly enhance our understanding of the innate molecular mechanisms underlying the interaction between type 2 inflammation in and viral exacerbations of asthma. The strong synergy among our projects will accelerate progress toward novel therapies by demonstrating that the innate immune components under study protect against viral infection in asthma.

这个U19哮喘和过敏性疾病合作研究中心（AACDRC）项目汇集了一个